欢迎来到 Bio-Helix中国区代理商/公司/官网
全国咨询热线: 15172431432
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18327026838

传真:18327026838

邮箱:sales@amyjet.com

新闻中心
OZ BIOSCIENCES.png

OZ Biosciences是一家法国的新兴生物技术公司,其成立宗旨是帮助药物公司研发和生产新型的药物导入系统。研究方向主要集中在生物活性材料导入活体组织新技术的研发,2005年该技术研发获得了突破性进展,已经申请了多项国际专利。

 

OZ Biosciences公司的创办者是分子导入系统的国际权威,在此领域享有极高的声望。研发目标是建立新一代的核酸、蛋白、多肽和其它生物分子的转染导入系统,为广大科研工作者服务。该公司与许多国际知名企业、大学和科研机构有合作往来。OZ Biosciences公司产品极具特色,主打产品是基于纳米技术和生物技术的基础上发展起来的磁转染试剂,相对常规商业化转染试剂,其转染效率更高。

 

Since 2003, OZ Biosciences creates, develops and produces innovative   molecular delivery systems specialized in transfection and transduction   tools, for the worldwide scientific community and pharmaceutical   industry. OZ Biosciences is focused on delivery technologies of   biomolecules such as DNA, RNA and protein for in vitro and in vivo   applications.

These past years, the life sciences have gone through a technological   revolution. The progress achieved in genomic, functional genomic and   proteomic areas has created fabulous opportunities for better   understanding of basic biological processes and for the development   of the next generation of medicines.

 

OZ Biosciences公司主要产品线:

(1)Magnetofection™: a unique gene delivery method for in vitro and in vivo applications.

(2)Lipofection: proprietary biodegradable lipid-based transfection reagents.

(3)Transduction tools: for producing, concentrating, storing and enhancing virus efficiency.

(4)3D transfection: allowing nucleic acid delivery directly into 3D matrix.

(5)Protein delivery systems: including antibody & based on biodegradable lipid nanoparticles.

(6)Cell specific reagents: For specific cells such as neurons and stem cells.

(7)Vaccine Adjuvants: Standard & novel adjuvants for antigenic & genetic immunization

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com


" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="OZ Biosciences">
OZ Biosciences
...
阅读详情
Life Diagnostics.png

Life Diagnostics公司专注于研发和生产临床前研究以及动物医学诊断相关的ELISA试剂盒、纯化的生物标志物和抗体等产品。产品覆盖心血管疾病、急性期反应、免疫毒性和免疫学标志物等研究领域,主要应用于小鼠、大鼠、兔、猫、狗、猪、猴和鸡等物种。此外,鉴于越来越多的研究围绕聚乙二醇化(PEGylated)生物制剂,Life Diagnostics公司也开发出了抗体PEG单克隆抗体和ELISA试剂盒用于检测PEG以及PEG化的蛋白。

 

Life Diagnostics manufactures ELISA kits, SPARCL™ kits, purified biomarkers and antibodies for preclinical research and veterinary diagnostics. Our areas of expertise include cardiovascular, acute phase, immunotoxicity and immunology biomarkers in species including mouse, rat, rabbit, cat, dog, pig, cow, monkey and chicken. Because of the increasing research into PEGylated biologics we have also developed anti-PEG monoclonal antibodies and ELISA kits for detection of PEG, mPEGylated proteins and anti-PEG antibodies. We manufacture all of the products listed on our website.

 

Life Diagnotics目前可提供用于检测骨骼肌肌钙蛋白-I(troponin-I)、肌红蛋白(myoglobin)、脂肪酸结合蛋白(fatty acid binding protein, FABP)以及肌球蛋白轻链(myosin light chain-1, MLC-1)等代表性标志分子的ELISA试剂盒;主要提供针对检测小鼠、大鼠、兔、狗、猪和猴等种属的检测试剂盒。与肌红蛋白蛋白和心脏型FABP不同,骨骼肌肌钙蛋白I特异性表达于骨骼肌细胞,因此为检测肌肉损伤的首选标志物分子。

 

Life Diagnotics生产的PEG试剂主要包括抗体、ELISA试剂盒以及PE化蛋白。

(1)PEG抗体

(2)PEG ELISA试剂盒:竞争法ELISA检测PEG化蛋白(含甲氧基,或不含甲氧基);夹心法ELISA快速检测甲氧基PEG(mPEG)和mPEG化蛋白;抗PEG IgG和IgM ELISA试剂盒用于检测小鼠、大鼠和猴血清或血浆中PEG抗体的水平。

(3)PEG化蛋白

 

此外,Life Diagnostics还提供PEG包被的微孔板和封闭缓冲液,专门设计用于免疫检测PEG或PEG化抗体。大多数商业化的ELISA试剂盒含有去垢剂如Tween-20(一种含有PEG的去垢剂)会干扰PEG的检测。Life Diagnostics公司提供的封闭缓冲液不含去垢剂和PEG, 可用于稳定包被有PEG或PEG抗体的平板。

 

Life Diagnostics除提供多种心肌标志物ELISA检测试剂盒之外,还生产多种纯化的心肌生物标志物蛋白,包括肌钙蛋白I、肌钙蛋白T、肌钙蛋白复合物、肌红蛋白和脂肪酸结合蛋白等,可提供来自不同物种包括人、小鼠、大鼠、豚鼠、兔、狗、猪、牛和猴的蛋白。

 

主要产品包括:

SPARCL Kits

Acute Phase Rgts. »

Cardiac Biomarkers »

Immunoglobulin Rgts. »

Immunotoxicity ELISA Kits

PEG Reagents »

Skeletal Muscle Rgts. »

Liver Biomarkers

Misc Biomarkers

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Life Diagnostics">
Life Diagnostics
...
阅读详情
Maine Standards.png

艾美捷代理全系列LGC Maine Standards线性校准品。


Maine Standards公司独有的VALIDATE®即用型试剂,可以帮助检验机构对要求的线性、校准和线性范围进行验证。

 

VALIDATE® ready-to-use kits are designed to assist in the documentation of linearity, calibration verification and verification of linear range required by many inspection agencies. VALIDATE® will also provide assistance when troubleshooting instrument systems, reagent problems and calibration anomalies. Multiple product configurations are available to meet the different needs of the many instrument systems available. Configurations are specifically formulated to maximize reportable ranges with minimum dilutions.

产品系列包括:VALIDATE® GC、VALIDATE® PCT、VALIDATE® Body Fluids、VALIDATE® IBC、VALIDATE® LP、VALIDATE® HbA1c、VALIDATE® TDM、VALIDATE® UC、VALIDATE® SP、VALIDATE® THY、VALIDATE® CM、VALIDATE® Anemia、VALIDATE® Fertility、VALIDATE® Tumor Markers、VALIDATE® VIT D、VALIDATE® OSMO、VALIDATE® WBG、VALIDATE® Hemostasis。


64e327dc020ab.png


更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com


产品列表及详情也可访问艾美捷科技丁香通商城:

https://vicbio.biomart.cn/supply/c_271529.htm






" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理LGC Maine Standards全系列线性校准品">
艾美捷科技代理LGC Maine Standards全系列线性校准品
...
阅读详情
Imanislife logo .png

<

艾美捷科技代理Imanis Life Sciences品牌全系列产品


Imanis Life Sciences是一家专注于再生医学、基因治疗、肿瘤学及溶瘤病毒疗法研究领域的生物技术公司。Imanis Life Sciences科研领域提供两大核心解决方案:溶瘤病毒治疗研究产品:供应用于溶瘤病毒疗法研究的专用病毒制剂;非侵入性影像检测试剂:提供适用于体外及体内研究的全系列试剂,包括报告基因细胞系、报告基因慢病毒载体及特异性抗体。Imanis Life Sciences公司的产品主要包括高品质报告基因细胞系、慢病毒载体及基因构建体、NIS与VSV特异性抗体以及全系列溶瘤病毒资源库。


ImanisLifeSciences页面.png


▍Imanis Life Sciences产品线

● 报告基因慢病毒载体与质粒体系:提供全系列报告基因慢病毒载体及配套质粒解决方案。

即用型病毒载体:安全高效的即用颗粒,适用于原代细胞等难转染细胞类型的报告基因递送(无需额外处理);

病毒包装质粒系统:用于自主制备慢病毒载体颗粒的完整质粒体系。

● 稳定细胞系产品线:提供支持肿瘤学及免疫肿瘤学体内外研究的全系列稳定细胞系。

组成型报告基因细胞系(持续表达):搭载荧光素酶、荧光蛋白或NIS报告基因。应用于体外药物筛选 / 活体动物肿瘤动态监测

肿瘤抗原工程细胞系(靶标调控型):经基因编辑调控常见肿瘤相关抗原及治疗靶点表达水平,核心靶标:CD19、EGFR、Her2

● 溶瘤病毒资源库:提供涵盖即用型病毒储备的完整解决方案,全面助力溶瘤病毒疗法的体内外研究进程。

● 抗体:提供优质的NIS抗体产品,全面兼容免疫印迹(WB)、免疫组化(IHC)、免疫荧光(IF)、流式细胞术,同时推出多功能抗VSV(水泡性口炎病毒)抗体,覆盖WB/IHC/IF/ELISA/流式及VSV中和实验全平台。


▍Imanis Life Sciences部分产品列表


品名规格货号
V-pNIS0.25 mL;1.0 mLLV053S;LV053L
LV-Ub-humanNIS-P2A-Puro0.25 mL;1.0 mLLV038S;LV038L
LV-PGK-humanNIS-P2A-Puro0.25 mL;1.0 mLLV036S;LV036L
LV-humanNIS-P2A-Puro0.25 mL;1.0 mLLV019S;LV019L
LV-humanNIS-IRES-Neo0.25 mL;1.0 mLLV013S;LV013L
LV-humanNIS0.25 mL;1.0 mLLV001S;LV001L
LV-EF1α-humanNIS-P2A-Puro0.25 mL;1.0 mLLV037S;LV037L
LV-CAG-humanNIS-P2A-Puro0.25 mL;1.0 mLLV042S;LV042L
LV-rhesusNIS-PGK-Puro0.25 mL;1.0 mLLV018S;LV018L
LV-rhesusNIS0.25 mL;1.0 mLLV017S;LV017L
LV-EF1α-rhesusNIS-PGK-Puro0.25 mL;1.0 mLLV040S;LV040L
LV-mouseNIS-P2A-Neo0.25 mL;1.0 mLLV025S;LV025L
LV-mouseNIS-PGK-Puro0.25 mL;1.0 mLLV022S;LV022L
Anti-human NIS antibody SJ10.25 mlREA004
Monoclonal anti-human NIS antibody (affinity purified)100 ulREA011
Anti-human (KELE) NIS antibody (affinity purified)100 ulREA010
Anti-human (ETNL) NIS antibody (affinity purified)100 ulREA009
Anti-human NIS antibody clone VJ20.25mLREA003
Anti-human NIS antibody clone VJ10.25mLREA002
Anti-rat NIS antibody (affinity purified)100 ulREA008
Anti-VSV antibody0.25mLREA005



" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Imanis Life Sciences品牌全系列产品">
艾美捷科技代理Imanis Life Sciences品牌全系列产品
...
阅读详情
Anogen.jpg

Anogen-Yes Biotech Laboratories Ltd. 创建于1989年, 位于加拿大多伦多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技术研究有限公司在国际上的市场经销部门。Anogen-Yes Biotech Laboratories Ltd.研发和生产各种新颖抗体及有关产品,应用广泛的技术平台设计和开发各种单克隆抗体、多克隆抗体、基因工程/人源化抗体、免疫检验用配对抗体、免疫球蛋白、活性多肽、酶联免疫试剂盒[ELISA]、斑点酶联免疫试剂盒[Elispots]和基因重组蛋白质等等。 这些产品主要用于生命科学研究和各种疾病的诊断和防治,包括炎症和自身免疫性疾病、心血管病和癌症等。

 

Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian biopharmaceutical company based in Mississauga, Ontario. Founded in 1989, Anogen-Yes Biotech specializes in developing and manufacturing monoclonal antibodies, recombinant proteins, synthetic bioactive peptides, and Enzyme linked immunosorbent assay (ELISA) kits for research as well as diagnostic and therapeutic use.[1] It is also committed to seeking medical treatment of cancer, autoimmune, inflammatory and cardiovascular diseases by developing antibody-based biopharmaceuticals.

 

Anogen的主要产品包括:

Monoclonal Antibodies

Polyclonal Antibodies

Matched Antibody Pairs

ELISA Kits

 

按照研究领域细分:

Inflammatory & Growth Factors

Cell Biology & Molecular Biology

Immunoassay Reagents

Infection & Toxin

Coagulation Factors

Hormone

Neurological Disorder

Tumor Research


品名货号规格
mAb anti-Human TNF-α, CH8810MO-C40003A0.1 mg
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, C2H9MO-C40003D0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, C2A7MO-C40003F0.1 mg
mAb anti-Human TNF-α, C5G7MO-C40003G0.1 mg
mAb anti-Human TNF-α, C4C7MO-C40003H0.1 mg
mAb anti-Human IFN-γ, 315MO-C40004D0.1 mg
mAb anti-Human IFN-γ, 165MO-C40004E0.1 mg
mAb anti-Human IFN-γ, 23MO-C40004F0.1 mg
mAb anti-Human CCR1, 293MO-C40005A0.1 mg
mAb anti-Human TGF-β, TB21MO-C40009A0.1 mg
mAb anti-Human TGF-β, 2C5MO-C40009B0.1 mg
mAb anti-Human TGF-β, 2C6MO-C40009D0.1 mg
mAb anti-Human TGF-β, 2E6MO-C40009E0.1 mg
mAb anti-Human TGF-β, 8C4MO-C40009F0.1 mg
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-61MO-C40017E0.1 mg
mAb anti-Human IL-8, 257MO-C40017F0.1 mg
mAb anti-Human IL-8, 807MO-C40017G0.1 mg
mAb anti-Human MCP-1, S8MO-C40021A0.1 mg
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, 9G10MO-C40021E0.1 mg
mAb anti-Human MCP-1, S382MO-C40021F0.1 mg
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 513MO-C40028D0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 291MO-C40028G0.1 mg
mAb anti-Human SAA, 504MO-C40028H0.1 mg
mAb anti-Human SAA, 585MO-C40028J0.1 mg
mAb anti-Human SAA, 426MO-C40028K0.1 mg
mAb anti-Human SAA, 38MO-C40028L0.1 mg
mAb anti-Human SAA, 132MO-C40028M0.1 mg
mAb anti-Human SAA, S3MO-C40028N0.1 mg
mAb anti-Human IL-1β, S1H12MO-C40029A0.1 mg
mAb anti-Human IL-1β, S1B7MO-C40029B0.1 mg
mAb anti-Human IL-1β, S3F12MO-C40029G0.1 mg
mAb anti-Human IL-1β, 464MO-C40029H0.1 mg
mAb anti-Human IL-2, 5A8,MO-C40032A0.1 mg
mAb anti-Human IL-2, 9F9,MO-C40032B0.1 mg
mAb anti-Human IL-2, 10C4MO-C40032C0.1 mg
mAb anti-Human IL-2, 8C2MO-C40032D0.1 mg
mAb anti-Human IL-2, 6F11MO-C40032E0.1 mg
mAb anti-Human IL-2, 6B1MO-C40032F0.1 mg
mAb anti-Human EGF, S-21MO-C40044A0.1 mg
mAb anti-Human EGF, S-120MO-C40044B0.1 mg
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-145MO-C40044E0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-147MO-C40044G0.1 mg
mAb anti-Human EGF, S-177MO-C40044H0.1 mg
mAb anti-Human G-CSFR, S-1252MO-C40045A0.1 mg
mAb anti-Human G-CSFR, S-1268MO-C40045B0.1 mg
mAb anti-Human G-CSFR, S-1284MO-C40045D0.1 mg
mAb anti-Human G-CSFR, S-1374MO-C40045E0.1 mg
mAb anti-Human G-CSFR, S-425MO-C40045F0.1 mg
mAb anti-Human G-CSFR, S-1390MO-C40045G0.1 mg
mAb anti-Human bFGF, F-343MO-C40046A0.1 mg
mAb anti-Human bFGF, F-74MO-C40046B0.1 mg
mAb anti-Human bFGF, F-474MO-C40046F0.1 mg
mAb anti-Human bFGF, F-3MO-C40046H0.1 mg
mAb anti-Human EPO, 85MO-C40047A0.1 mg
mAb anti-Human M-CSF, 116MO-C40048A0.1 mg
mAb anti-Human M-CSF, 692MO-C40048B0.1 mg
mAb anti-Human M-CSF, 21MO-C40048D0.1 mg
mAb anti-Human MIP-1α, 116MO-C40051A0.1 mg
mAb anti-Human MIP-1α, 125MO-C40051D0.1 mg
mAb anti-Human MIP-1α, 548MO-C40051F0.1 mg
mAb anti-Human MIP-1α, 199MO-C40051G0.1 mg
mAb anti-Human MIP-1α, 400MO-C40051L0.1 mg
mAb anti-Human MIP-1α, 103MO-C40051M0.1 mg
mAb anti-Human MIP-1α, 376MO-C40051N0.1 mg
mAb anti-Human MIP-1α, 426MO-C40051P0.1 mg
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 343MO-C40088B0.1 mg
mAb anti-Human MCP-3, 490MO-C40088D0.1 mg
mAb anti-Human MCP-3, 768MO-C40088E0.1 mg
mAb anti-Human MCP-3, 1057MO-C40088F0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 1015MO-C40088H0.1 mg
mAb anti-Human IL-16, 59MO-C40089G0.1 mg
mAb anti-Human IL-16, 210MO-C40089H0.1 mg
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 568MO-C40089M0.1 mg
mAb anti-Human IL-16, 572MO-C40089N0.1 mg
mAb anti-Human GM-CSF, 29MO-C40090A0.1 mg
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 204MO-C40090E0.1 mg
mAb anti-Human GM-CSF, 489MO-C40090F0.1 mg
mAb anti-Human GM-CSF, 120MO-C40090G0.1 mg
mAb anti-Human GM-CSF, 26MO-C40090H0.1 mg
mAb anti-Human GM-CSF, 174MO-C40090K0.1 mg
mAb anti-Human GM-CSF, S333MO-C40090L0.1 mg
mAb anti-Human IL-6, 2E10MO-C40091B0.1 mg
mAb anti-Human IL-6, 8E10MO-C40091C0.1 mg
mAb anti-Human IL-6, 5G8MO-C40091D0.1 mg
mAb anti-Human IL-6, 1B6MO-C40091E0.1 mg
mAb anti-Human IL-6, 1E3MO-C40091F0.1 mg
mAb anti-Human IL-6, 6D7MO-C40091G0.1 mg
mAb anti-Human IL-6, 9D8MO-C40091H0.1 mg
mAb anti-Human IL-10, 4H2MO-C40092A0.1 mg
mAb anti-Human IL-10, 6D2MO-C40092B0.1 mg
mAb anti Human IL-17A clone 4C1, CaptureMO-C40093A0.1mg
mAb anti Human IL-17A clone 2F3MO-C40093B0.1mg
mAb anti Human IL-17A clone 8H7MO-C40093C0.1mg
mAb anti Human IL-17A clone 5B4MO-C40093D0.1mg
mAb anti Human IL-17A clone 1E2MO-C40093E0.1mg
mAb anti Human IL-17A clone 2D11MO-C40093H0.1mg
mAb anti Human IL-17A clone 3C1MO-C40093I0.1mg
mAb anti Human IL-17A clone 3H11, DetectorMO-C40093K0.1mg
mAb anti Human IL-17A clone 5A9MO-C40093M0.1mg
mAb anti Human IL-17A clone 6F12MO-C40093O0.1mg
mAb anti Human IL-17A clone 7F10MO-C40093S0.1mg
mAb anti Human IL-17A clone 10F9MO-C40093W0.1mg
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti-human LIF, Clone 2C6MO-C40096A0.1mg
mAb anti-human LIF, Clone 3F4MO-C40096B0.1mg
mAb anti-human LIF, Clone 8B10MO-C40096C0.1mg
mAb anti-DYKDDDDK (Flag) Tag, Flag.10F4MO-H40001B0.1 mg
mAb anti-GAPDH, H8MO-H40002A0.1 mg
mAb anti-HA Tag, HA52MO-H40004A0.1 mg
mAb anti-His Tag, 10A12MO-H40005B0.1 mg
mAb anti-Myc Tag, MycA7MO-H40006A0.1 mg
mAb anti-V5 Tag, V531MO-H40007A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 163MO-I40002C0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 587, 0.1 mgMO-I40002E0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 425MO-I40002I0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 1027MO-I40002J0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 287MO-I40002N0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 161MO-I40002P0.1 mg
mAb anti-HBsAg, RM-1MO-I40013A0.1 mg
mAb anti-HCV Core Protein, A1/3D1MO-I40015A0.1 mg
mAb anti-HCV Core Protein, B2MO-I40015B0.1 mg
mAb anti-HCV Core Protein, C3MO-I40015E0.1 mg
mAb anti-HCV NS-4, 7B7/5G9MO-I40016B0.1 mg
mAb anti-HCV NS-4, 5D4/10E7MO-I40016D0.1 mg
mAb anti-HCV NS-4, 7E11MO-I40016F0.1 mg
mAb anti-HCV NS-4, 202MO-I40016J0.1 mg
mAb anti-HCV NS-4, 101MO-I40016K0.1 mg
mAb anti-HCV NS-4, 174MO-I40016L0.1 mg
mAb anti-HCV NS-4, 497MO-I40016M0.1 mg
mAb anti-HCV NS-3, 70-13MO-I40018A0.1 mg
mAb anti-HCV NS-3, 1-5MO-I40018B0.1 mg
mAb anti-HCV NS-3, 12-15MO-I40018D0.1 mg
mAb anti-HCV NS-3, 5-11MO-I40018E0.1 mg
mAb anti-HCV NS-3, 24-8MO-I40018F0.1 mg
mAb anti-HCV NS-3, 20-8MO-I40018G0.1 mg
mAb anti-HCV NS-3, 113MO-I40018H0.1 mg
mAb anti-HCV NS-3, 281MO-I40018J0.1 mg
mAb anti-HCV NS-3, 806MO-I40018K0.1 mg
mAb anti-HCV NS-3, 5MO-I40018L0.1 mg
mAb anti-HCV NS-3, 328MO-I40018M0.1 mg
mAb anti-HCV NS-3, 251MO-I40018N0.1 mg
mAb anti-HCV NS-3, 242MO-I40018P0.1 mg
mAb anti-HCV NS-3, 133MO-I40018Q0.1 mg
mAb anti-HEV, S-13MO-I40019B0.1 mg
mAb anti-HEV, 4H5MO-I40019C0.1 mg
mAb anti-HEV, 2H6MO-I40019D0.1 mg
mAb anti-HEV, 2H2MO-I40019E0.1 mg
mAb anti-HEV, 1B6MO-I40019F0.1 mg
mAb anti-HEV, 5H4MO-I40019G0.1 mg
mAb anti-HP CagA, 10E9,MO-I40020A0.1 mg
mAb anti-HP CagA, 5H10MO-I40020B0.1 mg
mAb anti-HP CagA, 5C6MO-I40020C0.1 mg
mAb anti-HP CagA, 3C10,MO-I40020D0.1 mg
mAb anti-HP CagA, 3C1MO-I40020E0.1 mg
mAb anti-TB 38KD Antigen, D2G2MO-I40021A0.1 mg
mAb anti-TB 38KD Antigen, C12H11MO-I40021B0.1 mg
mAb anti-TB 38KD Antigen, C11B10MO-I40021C0.1 mg
mAb anti-TB 38KD Antigen, B12F8MO-I40021D0.1 mg
mAb anti-TB 38KD Antigen, A11D2MO-I40021E0.1 mg
mAb anti-TB 38KD Antigen, A2H8MO-I40021F0.1 mg
mAb anti-Human CD3, JXT3MO-L40001A0.1 mg
Rat anti-Mouse CD4, JXYT4MO-L400260.1 mg
Rat anti-Mouse CD8, JXYT8MO-L400270.1 mg
mAb anti-Human CD11α, A11MO-L400280.1 mg
mAb anti-Human HLA-ABC, LY5.1MO-L400330.1 mg
mAb anti-Human CD71 Transferrin Receptor, CY-TFRMO-L400420.1 mg
mAb anti-Human PD-1 / CD279, 1C4MO-L40043A0.1 mg
mAb anti-Human PD-1 / CD279, 7C9, CaptureMO-L40043B0.1 mg
mAb anti-Human PD-1 / CD279, 9E11MO-L40043E0.1 mg
mAb anti-Human PD-1 / CD279, 9B4MO-L40043F0.1 mg
mAb anti-Human PD-1 / CD279, B1C4MO-L40043G0.1 mg
mAb anti-Human PD-1 / CD279, 7G12, DetectorMO-L40043L0.1 mg
mAb anti-Human PD-1 / CD279, 2H7MO-L40043M0.1 mg
mAb anti Human PD-L1, clone 6A5MO-L40044E0.1 mg
mAb anti Human PD-L1 clone 8C12MO-L40044F0.1 mg
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 11D11MO-L40044M0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti Human PD-L1 clone 12D9MO-L40044O0.1 mg
mAb anti Human PD-L1 clone 15F2MO-L40044R0.1 mg
mAb anti Human PD-L1, clone 10B12MO-L40044S0.1 mg
mAb anti Human CD47, clone 1G10MO-L40045A0.1 mg
mAb anti Human CD47, clone 8H7MO-L40045B0.1 mg
mAb anti Human CD47, clone 9F10MO-L40045C0.1 mg
mAb anti Human CD44, clone 2G7MO-L40046A0.1 mg
mAb anti Human CD44, clone 3C7MO-L40046B0.1 mg
mAb anti-hCG-α, CH5MO-M40010A0.1 mg
mAb anti-hCG-α, CH7MO-M40010B0.1 mg
mAb anti-TRICHOSANTHIN (TCST), TCST-1, 0.1 mgMO-M40011A0.1 mg
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-Human Ig Kappa Light Chain, YCK1MO-M400200.1 mg
mAb anti-Human B2MG, D6E4MO-M40021B0.1 mg
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D6D1MO-M40021D0.1 mg
mAb anti-Human B2MG, D2A10MO-M40021E0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human CRP, 67A1MO-M40023B0.1 mg
mAb anti-human CRP, N1G1MO-M40023D0.1 mg
mAb anti-human CRP, S5G1MO-M40023E0.1 mg
mAb Rat anti-Aflatoxin, 1C6, 0.1 mgMO-M40025A0.1 mg
mAb Rat anti-Aflatoxin, 1E6, 0.1 mgMO-M40025B0.1 mg
mAb Rat anti-Aflatoxin, 2E4MO-M40025D0.1 mg
mAb anti-Human Albumin, S4D6MO-M400360.1 mg
mAb anti-Human Factor IX, F9-1, .01 mgMO-M400370.1 mg
mAb anti-Human Protein C, HLW-C, 0.1 mgMO-M400380.1 mg
mAb anti-Human Factor X, F10-1, 0.1 mgMO-M400390.1 mg
mAb anti-Human GP IIb/IIIa, 237, 0.1 mgMO-M40040A0.1 mg
mAb anti-Human GP IIb/IIIa, 474, 0.1 mgMO-M40040B0.1 mg
mAb anti-Human GP IIb/IIIa, Y8MO-M40040D0.1 mg
mAb anti-Human GP IIb/IIIa, 700MO-M40040E0.1 mg
mAb anti-Human GP IIb/IIIa, 585MO-M40040F0.1 mg
mAb anti-Human GP IIb/IIIa, 8MO-M40040H0.1 mg
mAb anti-Human GP IIb/IIIa, 291MO-M40040J0.1 mg
mAb anti-Human GP IIb/IIIa, 262MO-M40040N0.1 mg
mAb anti-Human GP IIb/IIIa, 71MO-M40040Q0.1 mg
mAb anti-Human GP IIb/IIIa, 128MO-M40040S0.1 mg
mAb anti-Staphylococcal Enterotoxin B [SEB], 0.1 mgMO-M400410.1 mg
mAb anti-Human PTP1-C, PTY6MO-M40043A0.1 mg
mAb anti-Human PTP1-C, PTY11MO-M40043B0.1 mg
mAb anti-Human PTP1-C, PTY15MO-M40043D0.1 mg
mAb anti-Human PTP1-C, PTY10MO-M40043E0.1 mg
mAb anti-Human PTP1-C, PTY13MO-M40043F0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human Raf-1, 410MO-M40091E0.5 mg
mAb anti-Human Raf-1, 540MO-M40091G0.5 mg
mAb anti-Human Raf-1, 863MO-M40091J0.5 mg
mAb anti-Human Raf-1, 163MO-M40091M0.5 mg
mAb anti-Human NSE, 145MO-M40092A0.5 mg
mAb anti-Human NSE, 1G6MO-M40092B0.5 mg
mAb anti-Human NSE, 171MO-M40092C0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3B3MO-M40093A0.1 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3F8MO-M40093D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 3F5MO-M40094A0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1H3MO-M40094B0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 6C8MO-M40094C0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4A2MO-M40094E0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7H7MO-M40094F0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5A4MO-M40094G0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4B7MO-M40094H0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7G10MO-M40094I0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1F10MO-M40094J0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 8B2MO-M40095B0.1 mg
mAb anti-Amyloid β Peptide 40, 4B1MO-M40095C0.1 mg
mAb anti-Human α1-antitrypsin, 5G5MO-M40096A0.1 mg
mAb anti-Human α1-antitrypsin, 9F2MO-M40096B0.1 mg
mAb anti-Human α-Synuclein, 4H11MO-M40097A0.1 mg
mAb anti-Human α-Synuclein, 4C1MO-M40097B0.1 mg
mAb anti-Human α-Synuclein, 4B4MO-M40097C0.1 mg
mAb anti-Human α-Synuclein, 8F12MO-M40097D0.1 mg
mAb anti-Human α-Synuclein, 9A9MO-M40097E0.1 mg
mAb anti-Human α1-antichymotrypsin, 3E11MO-M40098A0.1 mg
mAb anti-Human α1-antichymotrypsin, B2B3MO-M40098B0.1 mg
mAb anti-Human α1-antichymotrypsin, B4H12MO-M40098C0.1 mg
mAb anti-Human α1-antichymotrypsin, B5B11MO-M40098D0.1 mg
mAb anti-Human α1-antichymotrypsin, B7B10MO-M40098E0.1 mg
mAb anti-Human α1-antichymotrypsin, B7H2MO-M40098F0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 1A4MO-M40099A0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 7G9MO-M40099B0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 9B4MO-M40099C0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 2A4MO-M40099D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1MO-M40100A0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 1G8MO-M40100B0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1MO-M40100C0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12MO-M40100D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1MO-M40100E0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11MO-M40100F0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11MO-M40100G0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 10G9MO-M40100H0.1 mg
mAb anti-LCRMP4, 5H5MO-M40101A/
mAb anti-LCRMP4, 2H7MO-M40101B/
mAb anti-LCRMP4 , 7E1MO-M40101C/
mAb anti-Human Phospho-STAT5b [p-Y699], A4B9MO-P40001A0.1 mg
mAb anti-Human Phospho-STAT5b [p-Y699], A2H6MO-P40001B0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], B4A12MO-P40002A0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], D7H2MO-P40002B0.1 mg
mAb anti-Human Phospho-CREB [p-S133], A3A4MO-P40003A0.1 mg
mAb anti-Human Phospho-CREB [p-S133], B1C4MO-P40003B0.1 mg
mAb anti-Human FPRL-1 C-terminal, C4F9MO-P40006A0.1 mg
mAb anti-Human FPRL-1 C-terminal, B4D9B10MO-P40006B0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, 3D7MO-P40007A0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, B7H10MO-P40007B0.1 mg
mAb anti-Human Lung Carcinoma, CHALU2MO-T40005B0.1 mg
mAb anti-Human Lung Carcinoma, 3504MO-T40005C0.1 mg
mAb anti-Human Hepatocellular Carcinoma, CHALV1MO-T40006A0.1 mg
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human BPH, YBPH-1MO-T40008A0.1 mg
mAb anti-Human BPH, YBPH-2MO-T40008B0.1 mg
mAb anti-Human PML, B3E9MO-T40010A0.1 mg
mAb anti-Human PML, B4C8MO-T40010B0.1 mg
mAb anti-CA 125, 110MO-T40012A0.1 mg
mAb anti-CA 125, 76MO-T40012B0.1 mg
mAb anti-CA 125, 23MO-T40012C0.1 mg
mAb anti-CA 125, 15MO-T40012D0.1 mg
mAb anti-CA 125MO-T40012E0.1 mg
mAb anti-CA50, 93MO-T40014A0.1 mg
mAb anti-CA50, 826MO-T40014B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,8E2 (Free Sample Available)MO-T40015A0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9B2 (Free Sample Available)MO-T40015B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,1A5 (Free Sample Available)MO-T40015C0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,4E11 (Free Sample Available)MO-T40015D0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9E1 (Free Sample Available)MO-T40015E0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7C4 (Free Sample Available)MO-T40015F0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7E6 (Free Sample Available)MO-T40015G0.1 mg
mAb anti-Human Colorectal Carcinoma, Y94MO-T400220.1 mg
mAb anti-Human Colorectal Carcinoma/CD3, BS-1MO-T400350.1 mg
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PMA, YPMA-1MO-T40083A0.1 mg
mAb anti-Human PMA, YPMA-2MO-T40083B0.1 mg
mAb anti-Human PSP, YPSP-1MO-T40085A0.1 mg
mAb anti-Human PSP, YPSP-2MO-T40085B0.1 mg
mAb anti-Human PSP, YPSP-3MO-T40085C0.1 mg
mAb anti-Human PSP, YPSP-4MO-T40085D0.1 mg
mAb anti-Human PSMA, YPSMA-1MO-T40086A0.1 mg
mAb anti-Human PSMA, YPSMA-2MO-T40086B0.1 mg
mAb anti-Human PSMA, 4H11MO-T40086C0.1 mg
mAb anti-Human PSMA, 7F3MO-T40086D0.1 mg
mAb anti-Human PTMA, 8H12MO-T40087A0.1 mg
mAb anti-Human PTMA, 9A10MO-T40087B0.1 mg
mAb anti-Human PTMA, 6A3MO-T40087C0.1 mg
mAb anti-Human PTMA, 4G2MO-T40087D0.1 mg
mAb anti-Human PTMA, 5A10MO-T40087E0.1 mg
mAb anti-Human PTMA, 6H7MO-T40087F0.1 mg
mAb anti-Human PTMA, 1F2, CaptureMO-T40087G0.1 mg
mAb anti-Human PTMA, 4C3MO-T40087H0.1 mg
mAb anti-Human PTMA, 4A7, DetectorMO-T40087I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9A4MO-T40088A0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E6MO-T40088B0.1 mg
mAb anti-Human S100A7 (psoriasin), 1A10MO-T40088C0.1 mg
mAb anti-Human S100A7 (psoriasin), 5C2MO-T40088D0.1 mg
mAb anti-Human S100A7 (psoriasin), 10H9MO-T40088E0.1 mg
mAb anti-Human S100A7 (psoriasin), 2A3MO-T40088F0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E5MO-T40088G0.1 mg
mAb anti-Human S100A7 (psoriasin), 5H12MO-T40088H0.1 mg
mAb anti-Human S100A7 (psoriasin), 9C7MO-T40088I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9D5MO-T40088J0.1 mg
mAb anti-Human S100A7 (psoriasin), 3E7MO-T40088K0.1 mg
Human PSA ELISA KitEL1000596 wells
Human IL-8 ELISA KitEL1000896 wells
Human MCAF / MCP-1 ELISA KitEL1000996 wells
Human EGF ELISA KitEL1001096 wells
Human LH ELISA KitEL1001196 wells
Human TSH ELISA KitEL1001296 wells
Neonatal TSH ELISA KitEL10012N96 wells
Ultra-Sensitive Human TSH ELISA KitEL10012U96 wells
Human FSH ELISA KitEL1001396 wells
Human Prolactin ELISA KitEL1001496 wells
Human SAA ELISA KitEL1001596 wells
Human SAA ELISA Kit (2nd Generation)EL10015L96 wells
Human MCP-3 ELISA KitEL1001696 wells
Human TNF-α ELISA KitEL1001996 wells
Human GM-CSF ELISA KitEL1002096 wells
Human IL-16 ELISA KitEL1002196 wells
High Sensitivity Human CRP ELISA KitEL10022hs96 wells
Human IL-6 ELISA KitEL1002396 wells
Human IFN-γ ELISA KitEL1002496 wells
Human IL-2 ELISA KitEL1002596 wells
Human IL-4 ELISA KitEL1002696 wells
Human IL-10 ELISA KitEL1002796 wells
Human IL-1β ELISA KitEL1002896 wells
Human TGF-β1 ELISA KitEL1002996 wells
Human Growth Hormone (hGH) ELISA Kit/Hormone ElisaEL1003096 wells
High Sensitivity Human Growth Hormone (H-hGH) ELISA KitEL10030H96 wells
Human Chorionic Gonadotropin (hCG) ELISA KitEL1003196 wells
Human IL-12 (P70) ELISA KitEL1003296 wells
Human IL-2 sRα ELISA KitEL1003396 wells
Human IL-6 sR ELISA KitEL1003496 wells
Human IL-5 ELISA KitEL1003596 wells
HAMA ELISA KitEL1003696 wells
Human IL-13 Rα2 ELISA KitEL1003996 wells
Human IL-1α ELISA KitEL1004096 wells
Human IL-7 ELISA KitEL1004196 wells
Human IL-11 ELISA KitEL1004296 wells
Human IL-15 ELISA KitEL1004496 wells
Human M-CSF ELISA KitEL1004696 wells
Human TNF-β ELISA KitEL1004796 wells
Human bFGF ELISA KitEL1004896 wells
Human Alphafetoprotein (AFP) ELISA KitEL1004996 wells
Human B2MG ELISA KitEL1005196 wells
Human Carcinoembryonic Antigen (CEA) ELISA KitEL1005296 wells
Human IL-17A ELISA KitEL1005396 wells
Human IL-13 ELISA KitEL1005496 wells
Human IL-22 ELISA KitEL1005596 wells
Human IL-9 ELISA KitEL1005696 wells
Human Amyloid Beta Peptide 42 ELISA KitEL1005796 wells
Human Programmed Death-Ligand 1 (PD-L1) ELISA KitEL1005896 wells
Human Programmed Death-1 (PD-1) ELISA KitEL1005996 wells
Human IL-18 ELISA KitEL1006096 wells
Multiplex Human Cytokine ELISA Kit (Inflammatory)EM1000196 wells
Multiplex Human Cytokine ELISA Kit (M1/M2/MDSC Cytokines)EM1000296 wells
Multiplex Human Cytokine ELISA Kit (Th1/Th2/Th17)EM1000396 wells
Mouse IL-17A ELISA KitMEC100196 wells
Mouse IFN-γ ELISA KitMEC100296 wells
Mouse TNF-α ELISA KitMEC100396 wells
Mouse GM-CSF ELISA KitMEC100496 wells
Mouse MCP-1 ELISA KitMEC100596 wells
Mouse IL-2 ELISA KitMEC100696 wells
Mouse IL-5 ELISA KitMEC100796 wells
Mouse IL-6 ELISA KitMEC100896 wells
Mouse IL-4 ELISA KitMEC100996 wells
Mouse IL-1β ELISA KitMEC101096 wells
Mouse IL-1α ELISA KitMEC101196 wells
Mouse TGF-β1 ELISA KitMEC101296 wells
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, B1E4, Tracer (HRP Labeled)MO-C40003T0.2 mL
mAb anti-Human TNF-α, B1E4, Tracer (Biotin Labeled)MO-C40003TB0.1 mL
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-60, Tracer (HRP Labeled)MO-C40017T0.2 mL
mAb anti-Human IL-8, I8-60, Tracer (Biotin Labeled)MO-C40017TB0.1 mL
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, S101, Tracer (HRP Labeled)MO-C40021T0.2 mL
mAb anti-Human MCP-1, S101, Tracer (Biotin Labeled)MO-C40021TB0.1 mL
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 607, Tracer (HRP Labeled), 0.2mLMO-C40028T0.2 mL
mAb anti-Human SAA, 607, Tracer (Biotin Labeled), 0.1mLMO-C40028TB0.1 mL
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-146, Tracer (HRP Labeled)MO-C40044T0.2 mL
mAb anti-Human EGF, S-146, Tracer (Biotin Labeled)MO-C40044TB0.1 mL
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 113, Tracer (HRP Labeled)MO-C40088T0.2 mL
mAb anti-Human MCP-3, 113, Tracer (Biotin Labeled)MO-C40088TB0.1 mL
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 323, Tracer (HRP Labeled)MO-C40089T0.2 mL
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 429, Tracer (HRP Labeled)MO-C40090T0.2 mL
mAb anti-Human GM-CSF, 429, Tracer (Biotin Labeled)MO-C40090TB0.1 mL
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti human IL-15 clone B1H6, Tracer (Biotin labeled)MO-C40095TB0.1 mL
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, Tracer (HRP), 0.2 mLMO-I40002T20.2 mL
mAb anti-Human PD-1 / CD279, 7G12, Tracer (Biotin labeled)MO-L40043TB0.1 mL
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti human PD-L1 clone 12B4, Tracer (Biotin Labeled)MO-L40044TB0.1 mL
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-hGH, YC8, Tracer (HRP Labeled), 0.2 mLMO-M40012T0.2 mL
mAb anti-hGH, YC8, Tracer (Biotin Labeled), 0.1 mLMO-M40012TB0.1 mL
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-Human B2MG, D3A2, Tracer (HRP Labeled), 0.2mLMO-M40021T0.2 mL
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-human TSH, TSH-2, Tracer (HRP Labeled), 0.2 mLMO-M40046T0.2 mL
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human Prolactin, PRL-2, Tracer (HRP Labeled), 0.2 mLMO-M40047T0.2 mL
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-Human LH, LH-2, Tracer (HRP Labeled), 0.2 mLMO-M40048T0.2 mL
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-hCG, HCG-2, Tracer (HRP Labeled), 0.2 mLMO-M40049T0.2 mL
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human FSH, FSH-2, Tracer (HRP Labeled)MO-M40050T0.2 mL
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, Tracer (Biotin)MO-M40093TB0.1 mL
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, Tracer (Biotin)MO-M40095TB0.1 mL
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human AFP, AFP-2, Tracer (HRP Labeled), 0.2 mLMO-T40007T0.2 mL
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human CEA, CEA-Y2, Tracer (HRP Labeled), 0.2 mLMO-T40051T0.2 mL
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human Free PSA, 103, Tracer (HRP Labeled), 0.2 mLMO-T40052T0.2 mL
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PSA, CHYH2, Tracer (HRP Labeled), 0.2 mLMO-T40081T0.2 mL
Human Chorionic Gonadotrophin (hCG), 10 mgAP3000210 mg
Human Immunoglobulin G (IgG), 10 mgIG3000110 mg
Mouse Immunoglobulin G (IgG), 10 mgIG4100210 mg
Mouse Immunoglobulin G2b (IgG2b), 10 mgIG4100410 mg
Rat Immunoglobulin G (IgG)IG4200310 mg
Human Umbilical Cord Serum, 10 mLS3001010 mL
ELISA Coating (EC) Stabilizer, 500 mLS7001500 mL
Human IL-8 Matched Antibody Pair for ELISpotSL10008A5 × 96 wells
Human IL-8 Development Set for ELISpotSL10008B5 × 96 wells
Human IL-8 ELISpot KitSL10008E6 X 96 wells
Human MCAF (MCP-1) Matched Antibody Pair for ELISpotSL10009A5 × 96 wells
Human MCAF (MCP-1) Development Set for ELISpotSL10009B5 × 96 wells
Human MCAF (MCP-1) ELISpot KitSL10009E6 X 96 wells
Human GM-CSF Matched Antibody Pair for ELISpotSL10020A5 × 96 wells
Human GM-CSF Development Set for ELISpotSL10020B5 × 96 wells
Human GM-CSF ELISpot KitSL10020E6 X 96 wells
Human IFN-γ Matched Antibody Pair for ELISpotSL10024A5 × 96 wells
Human IFN-γ Development Set for ELISpotSL10024B5 × 96 wells
Human IFN-γ ELISpot KitSL10024E6 X 96 wells
Human IL-12 (P70) ELISpot KitSL10032E6 X 96 wells
TMB Solution (500 mL Part A & 500 mL Part B)SU60061.0 L
pAb Rabbit anti-HCV Virus, 1.0 mgAI20006P1.0 mg
pAb Rabbit anti-HIV-1 p24, 1.0 mgAI20008P1.0 mg
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
pAb Rabbit anti-Mouse IgG , 1.0 mgAI500051.0 mg
pAb Rabbit anti-Mouse IgG - HRP Conjugated, 1.0 mLAI50005P1.0 mL
pAb Rabbit anti-hGH,AI50006P1.0 mg
pAb Chicken anti-human IL-8 (IgY fraction)AI600011.0 mg
pAb Rabbit anti-Human FPRL-1 2nd Extracellular LoopAI70001A0.1 mg
pAb Rabbit anti-Human FPRL-1 C-terminalAI70001B0.1 mg
pAb Rabbit anti-Human PML [Ring Finger Domain]AI70002A0.1 mg
pAb Rabbit anti-Human PML [B-box 1 domain]AI70002B0.1 mg
pAb Rabbit anti-Bcl-2AI70003A0.1 mg
pAb Rabbit anti-Phospho-Bcl-2 (Thr56)AI70003B0.1 mg
pAb Rabbit anti-Phospho-Bcl-xL (Thr115)AI70003D0.1 mg
pAb Rabbit anti-Phospho c-kit (Tyr719)AI70004A0.1 mg
pAb Rabbit anti-Phospho IKK-γ (Ser31)AI70005A0.1 mg
pAb Rabbit anti-NF-κB-p65 (RelA)AI70006A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser276)AI70007A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser468)AI70008A0.1 mg
pAb Rabbit anti-Phospho NF-қB-p105/p50 (Ser337)AI70009A0.1 mg
pAb Rabbit anti-Human Serum Albumin (HSA)AI800010.1 mg
pAb Rabbit anti-Human Fibrinogen, 0.1 mgAI800020.1 mg
pAb Rabbit anti-Human TransferrinAI800030.1 mg
pAb Rabbit anti-Human IgA, 0.5 mgAI800040.5 mg
pAb Rabbit anti-human IgM, 0.5 mgAI800050.5 mg
pAb Rabbit anti-Human TREK-1 (K2p2.1)AI80006A0.1 mg
pAb Rabbit anti-Mouse Kchip1AI800070.1 mg
pAb Rabbit anti-Mouse Kchip4AI800080.1 mg
pAb Rabbit anti-Mouse Kv4.3AI80010A0.1 mg
pAb Rabbit anti-Mouse TRPV1AI80011A0.1 mg
pAb Rabbit anti-Mouse TRPV3AI80012A0.1 mg
pAb Rabbit anti-Human JAK2AI80013A0.1 mg
pAb Rabbit anti-Human Glutathione S Transferase (GST), 0.1 mgAI800140.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 42AI900010.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 43AI900020.1 mg


" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Anogen">
Anogen
...
阅读详情
logo.png

<

艾美捷科技代理GenXPro品牌全系列产品


GenXPro GmbH成立于2005年,由来自法兰克福大学和巴黎大学的分子生物学家创立,是下一代测序(NGS)、qPCR和生物信息学创新解决方案的领先提供商。GenXPro公司专注于提供尖端的研究试剂盒、软件和数据分析工具,以快速、可靠地解析DNA、RNA、DNA甲基化和小RNA。作为定量基因组学的创新者,GenXPro在2008年获得了TrueQuant专利,这是一项利用唯一分子标识符(UMI)消除PCR引入偏差的突破性技术,该技术集成了几乎所有的技术和试剂盒,确保了最高准确性。其技术与应用包括多个方面:转录组学、基因组DNA分析、表观遗传学、微生物组学和宏基因组学、qPCR 和数字 qPCR 服务、生物信息学、cDNA 末端的大规模分析-MACE-SeqRNA-测序、smallRNA/miRNA-序列、16S rRNA V3-V4 微生物组测序、适配体和扩增子、健康与精准医疗、生物标志物、动植物育种、非模式生物、COVID-19/SARS-CoV-2 qPCR。


Genxpro页面.png


GenXPro公司主要服务

● 数据预处理:提供数据的解复用、清洗、过滤和质量检查服务,确保后续分析的数据质量。

● 比对和变异检出:能够将序列与所选的参考基因组进行比对,鉴定遗传变异、基因计数、转录本计数、p值和其他特征、图和质量信息,帮助用户深入了解基因层面的变化。

● 数据解释:运用复杂的算法和分析工具,方便用户获取全面的见解,使复杂的生物信息学数据更易于理解和应用。


MACE-Seq ServiceRNA-Seq ServiceExome-Seq Service5'-MACE-Seq Service
Degradome-Seq ServiceRibo-Seq ServiceMethyl-Seq ServiceCAGE-Seq Service
Whole-Genome-Seq ServicetRNA-Seq ServiceATAC-Seq ServicePanRNA-Seq Service
Targeted Metagenomics (16S/18S) ServicesmallRNA-Seq ServiceDNA-Seq ServiceCoV-Seq Service
Targeted Metagenomics (16S) ServiceAmplicon-Seq ServiceAptamer-Seq ServiceQC of RNA
<

GenXPro产品列表


品名产品描述
Control Human Reference RNAThis Control Human Reference RNA serves as a positive control for use with the TrueQuant MACE-Seq library preparation kit and other NGS protocols. It is suitable for various RNA-seq applications, including library preparation and sequencing workflows.
DNA Removal KitThe DNA Removal Supplementary Kit eliminates residual genomic DNA by specifically degrading DNA while preserving the integrity of RNA.
FFPE Enhancer for MACE-SeqFFPE Supplementary Kit is designed to adress Formalin-Fixed Paraffin-Embedded (FFPE) or substantial RNA degradated or fragmented samples, improving cDNA synthesis.
Nuclease-free Water-
qPCR Supplement Kit for MACE-SeqThe qPCR Supplementary Kit is designed to determine the precise cycle number required for the subsequent PCR amplification of the library
qPCR Supplement Kit for small RNA-SeqThe qPCR Supplementary Kit is designed to determine the precise cycle number required for the subsequent PCR amplification of the library.
TE Buffer-
TrueQuant MACE-Seq KitTrueQuant MACE-Seq Library Preparation Kit with UMI and UDI for in-house preparation of high-sensitive 3'mRNA-Seq including patented UMI-adapters (WO2009152928A2) for genome wide gene expression analyses of poly-adenylated RNA.
TrueQuant small RNA-Seq Kit (V2)TrueQuant small RNA-Seq Library Preparation Kit (V2) including patented UMI-adapters (WO2009152928A2) for high-sensitive smallRNA-Sequencing of any RNA between 20 and 80 bps, suited for EV-derived and single-cell amounts of RNA, detects miRNA, piRNA, siRNA. snRNA/U-RNA, snoRNA, srRNA, tRF, ysRNA viral or bacterial RNA.
RSE KitKit for region-specific extraction (RSE, Generation BIotech) for target enrichment prior to sequencing by NGS.
GXP-16s V3V4 rRNA KitKit for amplfication and sequencing of 16s rRNA-coding regions (V3 and V4) for high-resolution quantification of members of bacterial communities.
TrueQuant DNA Library Preparation Kit-
TQ-I5; Dual Index Adapter with p7+p5 UMI Index-
TQ-I7I5; Dual Index Adapter with p7+p5 UMI Index-
TQ-DNA-Seq-Library-Preparation Kit-
<< " data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理GenXPro品牌全系列产品">
艾美捷科技代理GenXPro品牌全系列产品
...
阅读详情
Bioporto.png

艾美捷科技特约代理BioPorto Diagnostics A/S公司产品。


BioPorto Diagnostics A/S公司成立于2001年,是丹麦一家专门生产抗体和基于抗体的各种生物产品的公司。BioPorto拥有Bioporto Diagnostics和Antibodyshop两个品牌,分别侧重于诊断试剂盒和抗体产品。在30多个国家有代理商,产品销售网络遍布全球,99%以上为出口销售。BioPorto Diagnostics旗下产品主要为几种临床快速诊断试剂盒,包括诊断早期急性肾损伤的NGAL ELISA kit,Gc-globulin ELISA kit ,评估原发性免疫缺陷的MBL Oligomer ELISA kit,同时还有相关其他种属的科研用试剂盒和抗原抗体。其最新推出的产品有检测人体血浆中的活性蛋白C-蛋白C抑制物(APC-PCI)复合物的APC-PCI ELISA kit,高纯度人IgE单克隆抗体,以及Glucagon-like peptide-1和Exendin-4相关的单抗。

 

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

< " data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Bioporto">
Bioporto
...
阅读详情

Copyright © 2026 Powered by Bio-Helix中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap